Author:
Huang Xiao-Jun,Liu Dai-Hong,Liu Kai-Yan,Xu Lan-Ping,Chen Yu-Hong,Wang Yu,Han Wei,Chen Huan
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy
Reference26 articles.
1. Robak T, Wrzesien-Kus A. The search for optimal treatment in relapsed and refractory acute myeloid leukemia. Leuk Lymphoma 2002;43:281–91.
2. Michallet M, Thomas X, Vernant JP, et al. Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM). Bone Marrow Transplant 2000;26:1157–63.
3. Slavin S, Naparstek E, Nagler A. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood 1996;87:2195–204.
4. Huang XJ, Guo NL, Ren HY, Xu LP, Chen H, Liu KY, et al. An improved anti-leukemic effect achieved with donor progenitor cell infusion for relapse patients after allogeneic bone marrow transplantation. Chinese Med J 2003;116:736–41.
5. Huang XJ, Liu DH, Xu LP, Chen H, Liu KY, Han W, et al. Prophylactic infusion of donor granulocyte colony stimulating factor mobilized peripheral blood progenitor cells after allogeneic hematological stem cell transplantation in patients with high-risk leukemia. Leukemia 2006;20:365–8.
Cited by
85 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献